Autoimmune inner ear disease: Diagnostic and therapeutic approaches in a multidisciplinary setting

Eric L. Matteson, David A. Fabry, Scott E. Strome, Colin L.W. Driscoll, Charles W. Beatty, Thomas J. McDonald

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Autoimmune Inner Ear Disease (AIED) is a clinical syndrome of uncertain pathogenesis. It is associated with bilateral rapidly progressive hearing loss. The hearing loss may be associated with vestibular symptoms. Autoimmunity has been proposed as the pathogenesis of this sort of hearing loss, although the mechanism of the disease is poorly understood. It is well accepted that the endolymphatic sac is an immunocompetent organ and circulating autoantibodies against inner ear antigens have been reported, as have viral antigens in the endolymph, although the sensitivity, specificity, and roles of those antibodies in a disease process are poorly defined. We will describe the clinical aspects of the disease, the histopathology, the immunologic indicators, the types of presentation, both from the audiologic and vestibular point of view, clinical trials for treatment and the follow-up. One of our conclusions is that many of these patients respond favorably to the treatment Methotrexate.

Original languageEnglish (US)
Pages (from-to)225-230
Number of pages6
JournalJournal of the American Academy of Audiology
Issue number4
StatePublished - Apr 2003


  • Autoimmune inner ear disease
  • Methotrexate
  • PET Scan
  • Sensorineural hearing loss

ASJC Scopus subject areas

  • Speech and Hearing


Dive into the research topics of 'Autoimmune inner ear disease: Diagnostic and therapeutic approaches in a multidisciplinary setting'. Together they form a unique fingerprint.

Cite this